A comprehensive new study published in Neurology has delivered encouraging news that should ease these concerns. The research, which tracked 13,571 healthy older adults over five years, found no ...

Key Takeaways Gepotidacin is the first new class of oral antibiotics for uUTIs in nearly 30 years, addressing rising drug resistance. Phase 3 trials showed gepotidacin's non-inferiority to ...

Ushering in a new class of antibiotics, the U.S. FDA approved GSK plc’s gepotidacin for use in uncomplicated urinary tract infections (uUTIs). Branded Blujepa, the oral triazaacenaphthylene bacterial ...